Immediate Impact

50 standout
Sub-graph 1 of 24

Citing Papers

Machine learning for functional protein design
2024 Standout
Gelable and Adhesive Powder for Lethal Non‐Compressible Hemorrhage Control
2023 Standout
2 intermediate papers

Works of Anders Rosholm being referenced

40K glycoPEGylated, recombinant FVIIa: 3‐month, double‐blind, randomized trial of safety, pharmacokinetics and preliminary efficacy in hemophilia patients with inhibitors
2013
Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency
2012
and 1 more

Author Peers

Author Last Decade Papers Cites
Anders Rosholm 203 90 47 227 177 20 623
Lesley Hordon 104 75 22 291 263 26 663
Jean‐Paul Eschard 279 39 30 80 68 29 626
April Kay 58 119 19 348 85 24 695
Dennis McGonagle 165 50 20 603 62 10 733
Aaron J. Schein 69 155 121 140 75 17 621
O. Kaye 95 96 68 400 33 21 623
F A Wollheim 48 52 29 326 55 22 673
Gordon Evison 129 73 43 480 40 28 722
C. Egsmose 140 24 22 425 43 21 566
Luca Di Geso 143 30 10 504 71 32 657

All Works

Loading papers...

Rankless by CCL
2026